Resection of Colorectal Liver Metastases After Second-Line Chemotherapy: Is It Worthwhile? A LiverMetSurvey Analysis of 6415 Patients

PURPOSE: Patient outcome after resection of colorectal liver metastases (CLM) following second-line preoperative chemotherapy (PCT) performed for insufficient response or toxicity of the first-line, is little known and has here been compared to the outcome following first-line. PATIENTS AND METHODS:...

Full description

Bibliographic Details
Main Author: Adam, R (author)
Other Authors: Yi, B (author), Innominato, PF (author), Barroso, E (author), Laurent, C (author), Giuliante, F (author), Capussotti, L (author), Lapointe, R (author), Regimbeau, JM (author), Lopez-Ben, S (author), Isoniemi, H (author), Hubert, C (author), Lin, JK (author), Gruenberger, T (author), Elias, D (author), Skipenko, OG (author), Guglielmi, A (author)
Format: article
Language:eng
Published: 2018
Subjects:
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Catheter Ablation
Cetuximab
Disease Progression
Disease-Free Survival
Female
Hepatectomy
Humans
Liver Neoplasms
Lymphatic Metastasis
Male
Middle Aged
Postoperative Care
Preoperative Care
Prospective Studies
Registries
Colonic Neoplasms
Rectal Neoplasms
CHLC CHBPT
Online Access:http://hdl.handle.net/10400.17/2922
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/2922

Internet

http://hdl.handle.net/10400.17/2922

Similar Items